rotenone has been researched along with Multiple Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arcangeli, S; Calabresi, P; Chiasserini, D; de Iure, A; Di Filippo, M; Ghiglieri, V; Tantucci, M; Tozzi, A | 1 |
| Avolio, C; Lia, A; Livrea, P; Papa, S; Pica, C; Ruggieri, M; Scacco, S; Trojano, M; Zimatore, GB | 1 |
2 other study(ies) available for rotenone and Multiple Sclerosis
| Article | Year |
|---|---|
Interferon-β1a protects neurons against mitochondrial toxicity via modulation of STAT1 signaling: electrophysiological evidence.
Topics: Animals; Corpus Striatum; Encephalomyelitis, Autoimmune, Experimental; Female; Interferon beta-1a; Interferon-beta; Mice; Mice, Inbred C57BL; Mitochondria; Multiple Sclerosis; Neurons; Neuroprotective Agents; Rats; Rotenone; STAT1 Transcription Factor; Uncoupling Agents | 2014 |
Glatiramer acetate induces pro-apoptotic mechanisms involving Bcl-2, Bax and Cyt-c in peripheral lymphocytes from multiple sclerosis patients.
Topics: Adult; Apoptosis; Apoptosis Regulatory Proteins; Apoptotic Protease-Activating Factor 1; bcl-2-Associated X Protein; Blotting, Western; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Case-Control Studies; Cytochromes c; Female; Glatiramer Acetate; Humans; Immunosuppressive Agents; Intracellular Signaling Peptides and Proteins; Lymphocytes; Male; Middle Aged; Multiple Sclerosis; Oxygen Consumption; Peptides; Proteins; Proto-Oncogene Proteins c-bcl-2; Rotenone; Statistics, Nonparametric; Time Factors; Uncoupling Agents | 2006 |